chrisvoncsefalvay/vaers-outcomes huggingface dataset:
196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent.; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent.) and NO ADVERSE EVENT (No adverse event) in a  patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On an unknown date, the patient experienced UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent.) and NO ADVERSE EVENT (No adverse event). At the time of the report, UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent.).    No concomitant drug information was provided.  It was unknown if the patient had received any other vaccine 4 weeks prior to COVID-19 vaccine.  No treatment drug information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 27-Dec-2022: Follow up appended where narrative updated
Fever over 100 for 4 days in a row, chills, extreme lethargy, no appetite; Fever over 100 for 4 days in a row, chills, extreme lethargy, no appetite; Fever over 100 for 4 days in a row, chills, extreme lethargy, no appetite; Fever over 100 for 4 days in a row, chills, extreme lethargy, no appetite; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 13-year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 31Jul2021 18:30 (Lot number: FA7484) at the age of 13 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: SERTRALINE. The following information was reported: PYREXIA (non-serious), CHILLS (non-serious), LETHARGY (non-serious), DECREASED APPETITE (non-serious) all with onset 01Aug2021 08:00, outcome "recovered" (2021) and all described as "Fever over 100 for 4 days in a row, chills, extreme lethargy, no appetite". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of pyrexia, chills, lethargy, decreased appetite.  Additional information: Patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination.  No follow-up attempts are possible. No further information is expected.
L arm redness/swelling/pain. Started on 12/11/209 - about 24 hrs later. Seen today 12/14/09. Started on BACTRIM DS.
Complaint of cough, chills, elevated temperature 102, sore/scratchy throat, and loss of taste/smell
I had the vaccine around 2:30. Around 6:15pm my heart started racing even if I was walking. I became dizzy, short of breath and just exhausted, and it got worse. After 24 hours I couldn't function and had to go to bed. Even a week later I was still fatigued and had shortness a breath. After 7 it started to linger away. I went for a walk a week later and was short of breath and went to dinner and was exhausted. I was hit by car and when I got a ct I had fluid in my heart which they didn't know whether it was from the vaccine or the accident.
Information has been received from a consumer who reported that her daughter had received 2 doses of GARDASIL and fell out of the 0, 2 and 6 months dosage periods as they forgot to return for the third vaccination. The patient was not experiencing any known symptoms. No additional information was provided. Additional information is not expected.
Redness, tenderness Lt upper arm after TDAP vaccine. Tx: warm compresses, E-MYCIN tid x 7 days.
3/20/2018 Mom called the clinic stating patient had broken out with a red rash and fever of 100 degrees. Symptoms started Sunday, 3/18/18. His MMR had been given 3/06/18. She was advised to keep him home until the rash and fever were gone. She has been treating the fever with TYLENOL which brought it down. A return call was made 3/22/18 9:45 AM. Mom stated the rash was almost gone and patient had been fever free for about 24 hours now. No other problems mentioned.
This case was reported by a healthcare professional and described the occurrence of vaccine underdose in a 2-month-old male subject who was vaccinated with ROTARIX (GlaxoSmithKline). Concurrent medical conditions included esophageal reflux and umbilical hernia. Concurrent vaccination included DTaP-IPV/HepB; GlaxoSmithKline; intramuscular; unknown given on 24 April 2013; Hib (non-gsk); non-GSK manufacturer; intramuscular; unknown given on 24 April 2013; pneumococcal vaccine (non-gsk); non-GSK manufacturer; intramuscular; unknown given on 24 April 2013. Concurrent medications included AXID and MYLICON. On 24 April 2013 the subject received 1st dose of ROTARIX (1 ml, oral) and experienced vaccine underdose. On 24 April 2013, within minutes of vaccination with ROTARIX, the subject experienced threw up. It was reported that the subject received ROTARIX successfully and concomitant vaccinations that were administered intramuscularly. The subject then cried which caused him to "spit up/throw up" the contents of his stomach. The immunization series was not discontinued or delayed. At the time of reporting the outcome of the event of threw up was unspecified. Follow up received from nurse on 28 May 2013. The nurse reported that the adverse event of threw up had resolved. The nurse did not feel that this adverse event was serious. The nurse documented that the event of "threw up" could have been associated with medical history or concurrent illness of gastroesophageal reflux disorder or "crying after vaccine administration (injections)." The nurse documented that the immunization series was not discontinued but was delayed. The nurse documented that the subject "received a repeat dose 9 days later" which was calculated to be administered on 3 May 2013 and symptoms did not recur following subsequent administration. The subject had not experienced any adverse events following previous vaccinations.
Client reports headache and neck ache beginning 5/24/12. Denies any further reactions.
Starting the day after the shot, patient was sick for 5 days with chills, fever, felt ill.
A medical assistant reported that the day after receiving vaccines the patient developed an injection site reaction characterized by an 8 cm area of induration, warmth, erythema, and edema on the left thigh. On 7/10/00 she was seen by the physician. This is 1 of 2 patients from this facility who developed an injection site reaction following receipt of Acel-Imune lot 470-527 or the concomitantly administered vaccine. A copy of this report has been forwarded to Aventis Pasteur, manufacturer of IPOL.
dose number: 3; dose number: 3; generalized skin rash; This is a spontaneous report from a contactable consumer or other non hcp.  A 80-years-old male patient received booster dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: 301558A, Expiry date: not reported) via an unspecified route of administration, administered in left arm on 29Sep2021 at 09:00 (Age at vaccination: 80 years old) as dose 3 (booster), single for covid-19 immunization. The patient medical history was unknown and concomitant medication included unspecified medication taken in two weeks along with Covid vaccine. Patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EL1283, Expiry date: not reported) via an unspecified route of administration, administered in left arm on 10Jan2021 at 11:00 (Age at vaccination: 80 years old) as dose 1, single for covid-19 immunization and second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EL8982, Expiry date: not reported) via an unspecified route of administration, administered in left arm on 31Jan2021 at 11:00 (Age at vaccination: 80 years old) as dose 2, single for covid-19 immunization. Patient did not take other vaccine in four weeks, patient was not tested for covid prior vaccination and not tested for Covid post vaccination. On 29Sep2021, patient took 3rd dose (off label and booster) and experienced generalized skin rash at 09:00. Patient received treatment for rash with Prednisone dose pack 5mg. Outcome of event generalized skin rash was recovered on an unspecified date in 2021.  Follow-up attempts are completed. No further information is expected
Patient took ibuprofen, 2 zyrtec, 2 pepcid and ubrelvy that morningat 7am.  Injection was administered at 9:30am, reaction started at 09:45am increased phelgm, severe migraine, tightness in chest, tongue swelling face swelling, patient took 4 zyrtec, 4 pepcid, ubrelvy. By 4pm tightness of chest and increased mucus subsides. That evening patient took 2 zyrtec 2 pepcid, 2 benadryl that evening, continued to have severe migraines, face and tongue swelling until 1/5/2021.
Injection site Soreness; tender; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Injection site Soreness) and VACCINATION SITE PAIN (tender) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Injection site Soreness) and VACCINATION SITE PAIN (tender). At the time of the report, VACCINATION SITE PAIN (Injection site Soreness) and VACCINATION SITE PAIN (tender) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment details were not provided.
Soreness; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Soreness) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high. Concomitant products included RIVAROXABAN (XARELTO) for Blood disorder, PRAVASTATIN for Cholesterol, VALSARTAN and AMLODIPINE for Hypertension, MULTIVITAMIN [VITAMINS NOS] and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 16-Mar-2021, the patient experienced MYALGIA (Soreness). On 19-Mar-2021, MYALGIA (Soreness) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.    This case was linked to MOD-2021-078059, MOD-2021-078068, MOD-2021-078029, MOD-2021-078048 (E2B Linked Report).; Sender's Comments:  MOD-2021-078059:Wife first dose case MOD-2021-078068:Wife second dose case MOD-2021-078029:Son first dose case MOD-2021-078048:Son second dose case
01/21 - numbness in face approx. 45min after injection 01/24 - numbness in face / muzzle area twice.  Less than 1/2 hr while in hospital observation room and approx. 45 min after injection 01/28 - numbness in muzzle area and back upper location sinus entry to throat.  Difficulty swa - llowing 02/04 -  Given diphenhydrAMINE (Benadryl) before vaccination.  Very slight numbness in face.  May or may not be vaccine related: 02/07/2023 High blood pressure / confusion / could not accurately describe symptoms / listed as fear (early symptom not related to this visit) / severe brain fog / got lost getting to hospital / no medications vision/fog cleared after approx. 45 min - ER Visit no diagnosis, however told it was related to the vaccine 02/14 - Primary DR High Blood Pressure / Brain Fog told it was vaccine related 02/21 - Primary Dr / Follow up to vaccine reaction 02/23 - Back pain and now recall neck stiffness undetermined date
Immediate difficulty breathing, abdominal pain, nausea, and redness at injection site.
Pt developed hives and wheezing. Treated with Benadryl and epinephrine and called EMS for transport to ER. A follow up report received 10/22/2001 adds: Reporter reports almost immediate onset of hives, wheezing after series of injections. Have been giving same shots except new lot of Flu vaccine. Pt denied egg sensitivity. Pt had no record of previous injections in previous 4 weeks. Treated and released from base ER.
Patient called on 10.11.2018 stating that her arm is hot to the touch, she stated she does not have a fever and there is no red streak going down her arm.
C/O large local swelling, site red, hot fever 101.3, nausea, body ache, Joint pain. Treated with Clindamycin for cellulitis. Possible Serum Sickness.
muscle pain; tiredness; generally feeling unwell (nausea and dizziness); generally feeling unwell (nausea and dizziness); generally feeling unwell (nausea and dizziness); This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 74 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 17Mar2021 09:30 (Lot number: EN6208) at the age of 74 years as dose 2,  single for covid-19 immunisation. Relevant medical history included: "dry eye" (unspecified if ongoing), notes: dry eye; "migraines" (unspecified if ongoing), notes: migraines; "scoliosis" (unspecified if ongoing), notes: scoliosis; "thyroid" (unspecified if ongoing), notes: thyroid; "osteoporosis" (unspecified if ongoing), notes: osteoporosis; "arthritis" (unspecified if ongoing), notes: arthritis; "allergy" (unspecified if ongoing), notes: Known allergies: yes. Concomitant medication(s) included: SYNTHROID; LIOTHYRONINE; VITAMIN D2; RESTASIS. Vaccination history included: Bnt162b2 (Lot number: EN6198, Lot unknown: False, Administration date: 24Feb2021, Administration time: 10:15 AM, Vaccine location: Left arm,, Dose number: 1, adverse event: Injection site pain, muscle pain next, adverse event start date:  25Feb2021), administration date: 24Feb2021, when the patient was 74 years old, for COVID 19 Immunisation, reaction(s): "Injection site pain"; Bnt162b2 (Lot number: EN6198, Lot unknown: False, Administration date: 24Feb2021, Administration time: 10:15 AM, Vaccine location: Left arm,, Dose number: 1, adverse event: Injection site pain, muscle pain next, adverse event start date:  25Feb2021), administration date: 24Feb2021, when the patient was 74 years old, for COVID-19 immunisation, reaction(s): "muscle pain", "slight fever". The following information was reported: MYALGIA (non-serious) with onset 18Mar2021, outcome "recovered" (2021), described as "muscle pain"; FATIGUE (non-serious) with onset 18Mar2021, outcome "recovered" (2021), described as "tiredness"; MALAISE (non-serious), NAUSEA (non-serious), DIZZINESS (non-serious) all with onset 18Mar2021, outcome "recovered" (2021) and all described as "generally feeling unwell (nausea and dizziness)". Therapeutic measures were not taken as a result of myalgia, fatigue, malaise, nausea, dizziness.  Additional Information: No other vaccine in four weeks. No COVID prior vaccination. No COVID tested post vaccination.  No follow-up attempts are possible. No further information is expected.
pt recv vax;started crying, cried 3 hr; to er; fever 106;
Client was pregnant at time of vaccination. She had consulted with 2 OBGYNS that are following her concerning if she should receive the covid vaccine. They both stated yes. She received her 1st covid vaccination to her left deltiod between 12pm - 1300 on 1/14/21. She did not experience any complications or feel any side effects immediately after vaccination. She was monitored by nursing staff for over 30 min to be prudent. On 1/16/21 the Sat following vaccination she began experiencing cramping in her stomach and began to bleed vaginally. She consulted w her OBGYN and was monitored. She miscarried on 1/19/21.
Information has been received from a physician's nurse concerning a male patient who on 26-APR-2011 was vaccinated subcutaneously with the first dose of ZOSTAVAX (Merck). On 07-MAY-2011 the patient developed a case of shingles. At the time of the report, the patient was recovering and working with their healthcare provider. Additional information has been requested.
PATIENT STATES THAT 2-3 WEEKS POST RECEIPT OF VACCINATION SHE BEGAN HAVING SEVERE NECH PAIN ON THE RIGHT SIDE (SAME SIDE OF BODY AS VACCINATION), BRAIN FOG, AND AN UNUSUAL TASTE IN MOUTH.  SHE IS STILL EXPERIENCING THESE SYMPTOMS.  SHE ALSO DEVELOPED DIFFICULTY BREATHING AND HAS BEEN PRESCRIBED SPIRIVIA RESPIMAT. (SHE WAS EVALUATED BY HER PHYSICIAN FOR THIS) SHE HAD SEVERE ANXIETY REQUIRING EMT EVALUATION ON  APRIL 15, 2021.
Patient came out of a sleep feeling numb all over and head felt empty.  Thrashed about on floor with muscle spasms in both legs.  Kept trying to hold onto head and not swallow the tongue.  The attempt to swallow the tongue went on for one hour, if the patient was reclining  on a bed.  If standing, the tongue felt sore.  The patient was still shaken, the next morning.
FACIAL FLUSHING; SLIGHTLY ELEVATED BLOOD PRESSURE; NIGHT SWEATS; CHILLS; MALAISE; NAUSEA; HEADACHE; This spontaneous report received from a patient concerned an adult female. The patient's height, and weight were not reported. The patient's concurrent conditions included allergy, and other pre-existing medical conditions included patient indicated that when she received allergy shots in the past she would experience some facial flushing &felt similar to how she felt post-janssen vaccine.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, expiry: UNKNOWN) .5 ml, administered on 08-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 08-MAR-2021, the subject experienced facial flushing. On 08-MAR-2021, the subject experienced slightly elevated blood pressure. On 08-MAR-2021, the subject experienced night sweats. On 08-MAR-2021, the subject experienced chills. On 08-MAR-2021, the subject experienced headache. On 08-MAR-2021, the subject experienced malaise. On 08-MAR-2021, the subject experienced nausea. Treatment medications included: diphenhydramine hydrochloride, and paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from slightly elevated blood pressure on 08-MAR-2021, and night sweats on 09-MAR-2021, and was recovering from facial flushing, chills, headache, nausea, and malaise. This report was non-serious.
Swelling at injection site, redness and swelling around elbow and an overall sick feeling.
Smallpox vax - redness around site w/some streaking; some chills, body aches, no fever; 8 cm area of erythema at site.
Significant arm soreness for 4 days, fever of 102.2 for 24 hours, body aches/joint pain for 24 hours, severe headache for 24 hours, lingering headache for 5 days, nausea 12 hours, fatigue for three days.  Have taken multiple doses of Tylenol 1000mg approximately every 8-10 hours for 5 days, ibuprofen 800mg every 8 hours for 1 day.  All symptoms resolved after 5 days.
Swelling about the size of my palm at injection site accompanied by redness and itching, severely swollen and painful lymph nodes with referred pain into breast tissue, mild fever, chills,  and nausea. Extreme fatigue. Fever, chills, nausea and fatigue were gone in about 24 hours. The lymph nodes and breast pain, swelling redness and itchiness at injection site are ongoing but getting better slowly
Pneumonia vaccination - 1st time taken. Felt slightly feverish day with shot; next day much worst. High fever 101 degrees (my normal temp is 97.6, low), weak & tried, am (where shot given) too sore to touch, tight chest. Took Tylenol, put on ice cap; called a relative who is a doctor in another state 10/12/09. Told Dr's office at UCSD.
Left arm injection site. There was redness and warmth followed by large circular area that persisted approximately 5-7 days. Incident occurred 7 days after injection. Itching for 1-2 days that was not distracting. No further care needed and therefore I only noted timeframe.
I received fever; nausea; diarrhea; chills; and malaise lasting 7 days. I took a prescription called PAXLOVID and I began to feel better.
Progress Notes (Nurse Practitioner) ? ? Hospitalist Expand AllCollapse All                                                                                           Subjective Patient is a 68 y.o. female who was seen at COVID Vaccine Clinic today for her first  dose of the COVID 19 vaccination.    She was given the Pfizer vaccination in the right deltoid muscle.   During her 15 minute waiting period after the injection, the patient began to experience lightheadedness, .  She denied rash.   This provider was notified of patient reaction and she was then assessed in the emergency bay area.   Monitored patient for severe reaction symptoms, including but not limited to blood pressure abnormality , chest pain, hypotension, increased swelling, rapid progression of symptoms and respiratory distress.         ALLERGY REVIEW OF SYSTEMS:  Patient complains of dizziness   CONT negative HENT negative Eyes negative Respiratory negative Skin negative GI negative Musculo negative     Previous Reactions: None    Objective    Vitals Vitals:   03/25/21 0852 BP: 132/71 BP Location: Left arm Patient Position: Sitting Pulse: 82 SpO2: 97%          Physical Exam Eyes:     Extraocular Movements: Extraocular movements intact.  Cardiovascular:     Rate and Rhythm: Normal rate and regular rhythm.  Pulmonary:     Effort: Pulmonary effort is normal.  Skin:    General: Skin is warm and dry.  Neurological:     General: No focal deficit present.     Mental Status: She is alert and oriented to person, place, and time.     Gait: Gait normal.  Psychiatric:        Mood and Affect: Mood normal.        Thought Content: Thought content normal.        Judgment: Judgment normal.         Assessment/Plan  Treatment included: had patient remove mask and provide calming measures.  Patient replaced mask before exiting clinic. Follow up response to treatment: good. Patient discharge: Stable to go home and follow up with PCP.  Differential Diagnosis: Vaccine-Related Anxiety (include misc mental health)   Patient responded to removing of facial mask and her lightheadedness resolved.  Patient ambulated out of clinic with steady gait.